These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 18202014)

  • 1. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.
    Clem B; Telang S; Clem A; Yalcin A; Meier J; Simmons A; Rasku MA; Arumugam S; Dean WL; Eaton J; Lane A; Trent JO; Chesney J
    Mol Cancer Ther; 2008 Jan; 7(1):110-20. PubMed ID: 18202014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation.
    Telang S; Clem BF; Klarer AC; Clem AL; Trent JO; Bucala R; Chesney J
    J Transl Med; 2012 May; 10():95. PubMed ID: 22591674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3).
    Emini Veseli B; Perrotta P; Van Wielendaele P; Lambeir AM; Abdali A; Bellosta S; Monaco G; Bultynck G; Martinet W; De Meyer GRY
    FEBS Lett; 2020 Sep; 594(18):3067-3075. PubMed ID: 32620030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer.
    Clem BF; O'Neal J; Tapolsky G; Clem AL; Imbert-Fernandez Y; Kerr DA; Klarer AC; Redman R; Miller DM; Trent JO; Telang S; Chesney J
    Mol Cancer Ther; 2013 Aug; 12(8):1461-70. PubMed ID: 23674815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PFKFB3 promotes endotoxemia-induced myocardial dysfunction through inflammatory signaling and apoptotic induction.
    Tian W; Guo HS; Li CY; Cao W; Wang XY; Mo D; Hao XW; Feng YD; Sun Y; Lei F; Zhang HN; Zhao MG; Li XQ
    Toxicol Appl Pharmacol; 2019 Apr; 368():26-36. PubMed ID: 30776389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis.
    Chesney J
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):535-9. PubMed ID: 16912547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
    O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
    Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.
    Rodríguez-García A; Samsó P; Fontova P; Simon-Molas H; Manzano A; Castaño E; Rosa JL; Martinez-Outshoorn U; Ventura F; Navarro-Sabaté À; Bartrons R
    FEBS J; 2017 Oct; 284(20):3437-3454. PubMed ID: 28834297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases.
    Yalcin A; Clem BF; Simmons A; Lane A; Nelson K; Clem AL; Brock E; Siow D; Wattenberg B; Telang S; Chesney J
    J Biol Chem; 2009 Sep; 284(36):24223-32. PubMed ID: 19473963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras transformation requires metabolic control by 6-phosphofructo-2-kinase.
    Telang S; Yalcin A; Clem AL; Bucala R; Lane AN; Eaton JW; Chesney J
    Oncogene; 2006 Nov; 25(55):7225-34. PubMed ID: 16715124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3PO inhibits inflammatory NFκB and stress-activated kinase signaling in primary human endothelial cells independently of its target PFKFB3.
    Wik JA; Lundbäck P; la Cour Poulsen L; Haraldsen G; Skålhegg BS; Hol J
    PLoS One; 2020; 15(3):e0229395. PubMed ID: 32130250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Akt/PKB and PFKFB isoenzymes in the control of glycolysis, cell proliferation and protein synthesis in mitogen-stimulated thymocytes.
    Houddane A; Bultot L; Novellasdemunt L; Johanns M; Gueuning MA; Vertommen D; Coulie PG; Bartrons R; Hue L; Rider MH
    Cell Signal; 2017 Jun; 34():23-37. PubMed ID: 28235572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3PO as a Selective Inhibitor of 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3 in A375 Human Melanoma Cells.
    Kotowski K; Supplitt S; Wiczew D; Przystupski D; Bartosik W; Saczko J; Rossowska J; Drąg-Zalesińska M; Michel O; Kulbacka J
    Anticancer Res; 2020 May; 40(5):2613-2625. PubMed ID: 32366406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
    Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
    Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3).
    Imbert-Fernandez Y; Clem BF; O'Neal J; Kerr DA; Spaulding R; Lanceta L; Clem AL; Telang S; Chesney J
    J Biol Chem; 2014 Mar; 289(13):9440-8. PubMed ID: 24515104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the sugar metabolism of tumors with a first-in-class 6-phosphofructo-2-kinase (PFKFB4) inhibitor.
    Chesney J; Clark J; Lanceta L; Trent JO; Telang S
    Oncotarget; 2015 Jul; 6(20):18001-11. PubMed ID: 26221874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.
    Lypova N; Telang S; Chesney J; Imbert-Fernandez Y
    J Biol Chem; 2019 Jul; 294(27):10530-10543. PubMed ID: 31126985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
    Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
    Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma.
    Li HM; Yang JG; Liu ZJ; Wang WM; Yu ZL; Ren JG; Chen G; Zhang W; Jia J
    J Exp Clin Cancer Res; 2017 Jan; 36(1):7. PubMed ID: 28061878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism.
    Klarer AC; O'Neal J; Imbert-Fernandez Y; Clem A; Ellis SR; Clark J; Clem B; Chesney J; Telang S
    Cancer Metab; 2014 Jan; 2(1):2. PubMed ID: 24451478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.